A similar pattern was seen for those using atypical antipsychotics; while males had the highest use in childhood, females were more likely to be prescribed these drugs in adulthood. However, the rate of growth increased more rapidly for men than women over the decade."These findings confirm that mental illness is a growing problem in the United States and that more patients are seeking needed therapy," said Muzina. "However, adequate monitoring by pharmacists and physicians and an open patient dialogue is imperative due to the complexities of mental illness and the risk of taking these medications inappropriately." Patients suffering from behavioral health disorders along with other related conditions benefit from the expertise of Medco's specialist pharmacists who have advanced training and expertise in these and other health conditions including diabetes, cardiovascular disease, pulmonary conditions and cancer. Specialist pharmacist are also better equipped to identify and address medication adherence problems which is especially important for those with mental health conditions since research shows these patients are more prone to poor adherence with medications used to treat comorbidities such as diabetes, asthma and heart disease and, in general, have poorer health outcomes. For more information on mental health medication use, visit America's State of Mind Report at www.medco.com/media About Medco Medco Health Solutions, Inc. (NYSE: MHS) is pioneering The world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for millions of Americans. With more than 20,000 employees worldwide dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2011 revenues of $70 billion, Medco ranks 34th on the 2011 Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. For more information, go to http://www.medcohealth.com. This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.